http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1035851-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ad66884a6f2a66126d492e56e09be39
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
filingDate 1998-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ec5792a2061f5f82918d4ff28ad035c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c60ddfd48f380eb81412a000ca2b937a
publicationDate 2001-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1035851-B1
titleOfInvention Endothelin receptor antagonists for combating hyperlipidaemia
abstract Diseases caused by obesity are treated with endothelin receptor antagonists. Diseases treated include those frequently associated with obesity such as hypertension, type 2 diabetes, hyperlipidemia, chronic kidney failure, arteriosclerosis and gout.
priorityDate 1997-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35799
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID348
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID300438
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID387529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127963291
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281004
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100683160
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449586
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373644
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408288
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43105
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID476438
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281276
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16835
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395103
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8674055
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID455722
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25728
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11816
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700386

Total number of triples: 60.